Sign in
Taking people in United StatesNo phase

Breathing Support After Breathing Tube Removal in Severely Obese Patients

Tests noninvasive breathing support after tube removal in adults with severe obesity.

Key facts

Who runs it
Rush University Medical Center
Where
Chicago, Houston, Milwaukee, and Winfield, United StatesSee the 4 sitesAlso in 1 other country, 1 site
Trial code
Registry title
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Status
Recruiting
People taking part
250 people, planned
Started
10 Jul 2023
Expected to end
1 Dec 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Noninvasive ventilation alternating with high flow nasal cannula
  • High flow nasal cannula
Record updated
7 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with severe obesity who have been on a breathing machine for at least 24 hours and are about to have the breathing tube removed.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Severe obesity (BMI 40 kg/m2 or higher) and on a breathing machine for 24 hours or more, with a planned removal of the breathing tube.
Earlier treatment
Must have had invasive mechanical ventilation for 24 hours or more.
Biomarker or test result
Blood pH of 7.35 or higher (arterial) or 7.31 or higher (venous) within 30 minutes of the spontaneous breathing trial (SBT).

Main reasons for not taking part

  • Pregnant
  • Using extra-corporeal membrane oxygenation
  • Has a chronic tracheostomy
  • Breathing tube removed by accident or unplanned, or as end-of-life care
  • Intubated because of an acute flare-up of COPD, or has a neuromuscular disease

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Adult, age ≥ 18 years old
  • Receiving invasive mechanical ventilation for ≥24 hours
  • BMI ≥40 kg/m2
  • Undergoing planned extubation per treating team
  • Arterial pH ≥7.35 or venous pH ≥ 7.31 within 30 mins of spontaneous breathing trial (SBT)

Who cannot take part

  • Underlying neuromuscular disease
  • Documented/known history of chronic hypercapnic respiratory failure on home NIV (including bilevel PAP)
  • Pregnant
  • Use of extra-corporeal membrane oxygenation
  • Chronic tracheostomy in place
  • Unplanned or accidental extubation
  • Terminal/compassionate extubation
  • Contraindication to NIV use
  • Intubated because of an acute exacerbation of COPD
  • No reintubation requested by patient/family
  • Enrolled in any other outcome study
  • Treating clinician feels that HFNC or NIV are either mandatory or contraindicated for a given patient

Where in United States

Also in 1 other country, 1 site

  • Rush University Medical CenterChicago, United StatesContact: Ramandeep Kaur, PhDTaking people
  • McGovern Medical School, The University of Texas Health Science CenterHouston, United StatesContact: Rosa M. Estrada-Y-Martin, MDTaking people
  • Medical College of WisconsinMilwaukee, United StatesContact: Rahul Nanchal, MDTaking people
  • Central DuPage HospitalWinfield, United StatesContact: Ankeet PatelNot yet recruiting

About the trial

What the trial wants to find out

Around 20% of the obese patients with higher body mass index (BMI) who are taken off the breathing tube and breathing machine (ventilator) end up needing it back to support breathing. The re-application of breathing tube is associated with poor outcomes, including high risk of pneumonia, longer hospital stays, and death. The purpose of this study is to assess if prophylactic use of noninvasive breathing support after removing the breathing tube lowers the chance of needing the breathing tube again.

The 2 groups in the trial

  • Intervention Group (NIV with HFNC)Treatment being tested

    Patients randomized to the intervention group will receive NIV alternating with HFNC for 24 hours after extubation

    Treatment: Noninvasive ventilation alternating with high flow nasal cannula

  • Control Group (HFNC alone)Existing treatment, for comparison

    Patients randomized to the intervention group will receive HFNC only for 24 hours after extubation

    Treatment: High flow nasal cannula

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Randomized Controlled Trial of Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Plain-language title
Breathing Support After Breathing Tube Removal in Severely Obese PatientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 August 2026